{"id":536963,"date":"2021-04-06T01:20:01","date_gmt":"2021-04-06T01:20:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=536963"},"modified":"2021-04-06T01:20:01","modified_gmt":"2021-04-06T01:20:01","slug":"injectable-drug-delivery-industry-supply-chain-analysis-growth-opportunities-top-companies-revenue-growth-and-business-development-report-by-2027","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/injectable-drug-delivery-industry-supply-chain-analysis-growth-opportunities-top-companies-revenue-growth-and-business-development-report-by-2027_536963.html","title":{"rendered":"Injectable Drug Delivery Industry Supply Chain Analysis, Growth Opportunities, Top Companies, Revenue Growth and Business Development Report by 2027"},"content":{"rendered":"<div style=\"font-style:italic; padding:8px 0px;\">The growing prevalence of chronic diseases and technological innovations are driving the demand of the market.<\/p>\n<\/div>\n<p style=\"text-align: justify;\"><strong><em>Market Size &ndash; USD 525.37 billion in 2019, Market Growth &#8211; CAGR of 11.3%, Market Trends &ndash; Increasing prevalence of chronic disorders<\/em><\/strong><\/p>\n<p style=\"text-align: justify;\">The global&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.emergenresearch.com\/industry-report\/injectable-drug-delivery-market\">Injectable Drug Delivery Market<\/a>&nbsp;is expected to reach USD 1,235.53 Billion by 2027, according to a new report by Emergen Research. The growth of this market is attributed to the increase in the number of chronic diseases, which has led to the growing usage of disposable syringes. The cost-effectiveness and hassle-free procedure of the Injectable Drug Delivery devices is also an essential factor in the increasing demand for the product. Increasing research and development for the technological advancement of the devices in order to make them more convenient for the patients is augmenting the demand for the industry.<\/p>\n<p style=\"text-align: justify;\"><strong>Request a sample copy of the report <\/strong><strong>@ <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.emergenresearch.com\/request-sample\/112\"><strong>https:\/\/www.emergenresearch.com\/request-sample\/112<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Key Market Competitors <\/strong><\/p>\n<p style=\"text-align: justify;\">The global Injectable Drug Delivery industry is widely fragmented due to the presence of numerous competitors across several regional and local segments of the market. These players are said to dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies operating in this market are in high competition with one another in terms of technological capabilities, product development and innovation, and product pricing strategies.<\/p>\n<p style=\"text-align: justify;\">Key participants include <strong>Terumo Corporation, Eli Lilly and Company, Becton, Dickson and Company, Pfizer, Inc., Baxter International, Inc., Schott AG, Bespak, Elcam Medical, Gerresheimer Ag, and Sandoz, among others.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Emergen Research has segmented the global Injectable Drug Delivery Market on the basis of Product Type, Therapeutic Application, End-User, and region:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Product Type Outlook (Revenue, USD Billion; 2017-2027)<\/strong>\n<ul>\n<li>Formulations<\/li>\n<li>Devices<\/li>\n<\/ul>\n<\/li>\n<li><strong>Therapeutic Application Outlook (Revenue, USD Billion; 2017-2027)<\/strong>\n<ul>\n<li>Hormonal disorders<\/li>\n<li>Autoimmune disorders<\/li>\n<li>Oncology<\/li>\n<li>Others<\/li>\n<\/ul>\n<\/li>\n<li><strong>End-User Outlook (Revenue, USD Billion; 2017-2027)<\/strong>\n<ul>\n<li>Homecare settings<\/li>\n<li>Hospitals &amp; Clinics<\/li>\n<li>Others<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>The Global Injectable Drug Delivery Market can be geographically bifurcated on the basis of regional demand, output, and estimated revenue share. The most prominent regions dictating the global market include:&nbsp; <\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>North America (U.S., Canada, Mexico)<\/li>\n<li>Europe (U.K., Germany, France, Italy)<\/li>\n<li>Asia Pacific (China, Japan, India, Korea)<\/li>\n<li>Latin America (Brazil, Argentina, Ecuador, Chile)<\/li>\n<li>Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran)<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Request customization of the report @ <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.emergenresearch.com\/request-for-customization\/112\"><strong>https:\/\/www.emergenresearch.com\/request-for-customization\/112<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\"><strong>The following are the main reasons to buy the Global Injectable Drug Delivery Market report:<\/strong><\/p>\n<ol style=\"text-align: justify;\">\n<li>The latest report closely evaluates the overall market size and infers on various aspects, such as the current business trends, market share, product offerings, and product share.<\/li>\n<li>It offers a detailed account of the end-use applications of the products &amp; services offered by this industry.<\/li>\n<li>It offers an insightful analysis of the various regional segments of the market that are projected to witness enormous growth over the forecast period.<\/li>\n<li>Furthermore, the report covers the latest developments taking place in the market and effective business strategies implemented by the leading market rivals.<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>The report considers the following market growth estimation timeline:<\/strong><\/p>\n<ol style=\"text-align: justify;\">\n<li>Historical Years: 2017-2018<\/li>\n<li>Base Year: 2019<\/li>\n<li>Estimated Year: 2027<\/li>\n<li>Forecast Years: 2020-2027<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>Table of Content<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Chapter 1. Methodology &amp; Sources<\/strong><br \/> &nbsp; &nbsp; 1.1. Market Definition<br \/> &nbsp; &nbsp; 1.2. Research Scope<br \/> &nbsp; &nbsp; 1.3. Methodology<br \/> &nbsp; &nbsp; 1.4. Research Sources<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1.4.1. Primary<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1.4.2. Secondary<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1.4.3. Paid Sources<br \/> &nbsp; &nbsp; 1.5. Market Estimation Technique<br \/> <strong>Chapter 2. Executive Summary<\/strong><br \/> &nbsp; &nbsp; 2.1. Summary Snapshot, 2019-2027<br \/> <strong>Chapter 3. Key Insights<\/strong><br \/> <strong>Chapter 4. Injectable Drug Delivery Market Segmentation &amp; Impact Analysis<\/strong><br \/> &nbsp; &nbsp; 4.1. Injectable Drug Delivery Market Material Segmentation Analysis<br \/> &nbsp; &nbsp; 4.2. Industrial Outlook<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.2.1. Market indicators analysis<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.2.2. Market drivers analysis<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.2.2.1. Increase in the number of chronic diseases<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.2.2.2. Growth in the Biologics Market<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.2.2.3. Technological advancement of the products<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.2.3. Market restraints analysis<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.2.3.1. Product recalls by the manufacturers<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.2.3.2. Needlestick infections and injuries<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.2.3.3. High cost associated with the devices<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.2.3.4. Present challenging economic conditions due to the pandemic<br \/> &nbsp; &nbsp; 4.3. Technological Insights<br \/> &nbsp; &nbsp; 4.4. Regulatory Framework<br \/> &nbsp; &nbsp; 4.5. Porter&rsquo;s Five Forces Analysis<br \/> &nbsp; &nbsp; 4.6. Competitive Metric Space Analysis<br \/> &nbsp; &nbsp; 4.7. Price trend Analysis<br \/> &nbsp; &nbsp; 4.8. Covid-19 Impact Analysis<\/p>\n<p style=\"text-align: justify;\"><strong>Chapter 5. Injectable Drug Delivery Market By Product type Insights &amp; Trends, Revenue (USD Million), Volume (Kilo Tons)<\/strong><br \/> &nbsp; &nbsp; 5.1. Product type Dynamics &amp; Market Share, 2019 &amp; 2027<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 5.1.1. Formulations<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 5.1.2. Devices<\/p>\n<p style=\"text-align: justify;\"><strong>CONTINUED&hellip;!!<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>To get the full coverage of the global Injectable Drug Delivery market @ <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.emergenresearch.com\/industry-report\/injectable-drug-delivery-market\"><strong>https:\/\/www.emergenresearch.com\/industry-report\/injectable-drug-delivery-market<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">Thank you for reading our report. To know more about the report, please connect with us, and our team will ensure the report is customized to meet your requirements.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/emergenresearch.com_68509.html\" rel=\"nofollow\">Emergen Research<\/a><br \/><strong>Contact Person:<\/strong> Eric Lee<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=injectable-drug-delivery-industry-supply-chain-analysis-growth-opportunities-top-companies-revenue-growth-and-business-development-report-by-2027\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +1 (604) 757-9756<br \/><strong>Address:<\/strong>14671 110 Avenue  Surrey, British Columbia, V3R2A9<br \/><strong>City:<\/strong> Surrey<br \/><strong>State:<\/strong> British Columbia<br \/><strong>Country:<\/strong> Canada<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.emergenresearch.com\/industry-report\/injectable-drug-delivery-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.emergenresearch.com\/industry-report\/injectable-drug-delivery-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.emergenresearch.com\/industry-report\/injectable-drug-delivery-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=injectable-drug-delivery-industry-supply-chain-analysis-growth-opportunities-top-companies-revenue-growth-and-business-development-report-by-2027\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The growing prevalence of chronic diseases and technological innovations are driving the demand of the market. Market Size &ndash; USD 525.37 billion in 2019, Market Growth &#8211; CAGR of 11.3%, Market Trends &ndash; Increasing prevalence of chronic disorders The global&nbsp;Injectable &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/injectable-drug-delivery-industry-supply-chain-analysis-growth-opportunities-top-companies-revenue-growth-and-business-development-report-by-2027_536963.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[408],"tags":[],"class_list":["post-536963","post","type-post","status-publish","format-standard","hentry","category-Electronics-Semiconductors"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/536963","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=536963"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/536963\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=536963"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=536963"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=536963"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}